6533b81ffe1ef96bd127852a

RESEARCH PRODUCT

Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease

V. Di MarcoSalvatore PettaDaniela CabibiCalogero CammàAntonio Craxì

subject

medicine.medical_specialtyHepatologybusiness.industryFatty liverGastroenterologyNon alcoholicDiseasemedicine.diseaseLogistic regressionGastroenterologyEndocrinologyInternal medicineMedicinePharmacology (medical)In patientHyperuricemiaLiver damageSteatosisbusiness

description

SUMMARY Background Hyperuricemia has been associated with metabolic disorders. In this line recent studies observed an independent link between higher uric acid serum levels and clinical diagnosis of non-alcoholic fatty liver disease (NAFLD). Mean uric acid serum level was 5.75 mg ⁄ dL, and about 20% of patients had hyperuricemia, that was independently associated with younger age (OR 0.951, 95% CI 0.918-0.984, P = 0.004), lobular inflammation (OR 2.144, 95% CI 1.055-4.357, P = 0.03) and steatosis grade (OR 1.859, 95% CI 1.078-3.205, P = 0.02), by multivariate logistic regression analysis. Female gender (OR 2.656, 95% CI 1.190-5.928, P = 0.01), higher HOMA index (OR 1.219, 95% CI 1.043- 1.426, P = 0.01), and hyperuricemia (OR 4.906, 95% CI 1.683-14.296, P = 0.004) were linked to NAFLD activity score (NAS) ‡ 5 by multiple logistic regression analysis. Conversely, higher HOMA index (OR 1.140, 95% CI 1.001- 1.229, P = 0.04), and NAS (OR1.954, 95% CI 1.442-2.649, P< 0.001) were inde- pendently associated with significant fibrosis by logistic regression analysis.

https://doi.org/10.1111/j.1365-2036.2011.04788.x